Clinical trials: ACS
Acute Coronary Syndrome, Coronary Stent Implantation
A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
This study is to evaluate the safety and efficacy of 60mg ticagrelor plus 100mg Aspirin to prevent major adverse cardiovascular and cerebrovascular events in one years after drug-eluting stents implantation for Chinese ACS…
- Trial name
- TIGER (NCT04255602)
- Testing
- Ticagrelor 60mg, Ticagrelor 90mg
- Where
- 8 sites in China
- Volunteers
- 2,120 people
- Sponsor
- Shanghai Tong Ren Hospital
Non ST Segment Elevation Acute Coronary Syndrome, Chronic Kidney Disease
COmparison of the Pharmacodynamics and Pharmacokinetics Ticagrelor Versus Clopidogrel in Patients With CKD and NSTE-ACS
Ticagrelor, a new P2Y12 receptor antagonist, achieve faster, consistent and higher platelet inhibition than clopidogrel, which was considered more noticeable in patients with ACS combining chronic kidney disease(CKD).
- Trial name
- OPT-CKD (NCT02578537)
- Testing
- Ticagrelor, Clopidogrel
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Shenyang Northern Hospital
Coronary Artery Disease, Acute Coronary Syndrome
Shanghai Registry of Acute Coronary Events
SRACE is an multicenter observational database of outcomes for patients who are hospitalized with an acute coronary events. SRACE includes over 20 hospitals in Shanghai China that have enrolled a total of more than 3,000 patients…
- Trial name
- NCT00713557
- Testing
- drug-eluting stent, Tirofiban
- Where
- China
- Volunteers
- 20,000 people
- Sponsor
- Shanghai Jiao Tong University School of Medicine
Acute Coronary Syndrome
Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)
This clinical trial is being conducted to 1) evaluate the possible usefulness of a panel of cardiac markers in assessing emergency department patients with possible acute coronary syndrome, 2) evaluate the usefulness of BNP in…
- Trial name
- NCT00206817
- Testing
- Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP)
- Where
- 6 sites in United States
- Sponsor
- Abbott RDx Cardiometabolic
Acute Coronary Syndrome
Short and Long Term Outcomes of Acute Coronary Syndrome in Patients With Non Obstructive Coronary Atherosclerosis
The purpose of the study is to assess short and long term outcomes of acute coronary syndrome in patients with non obstructive coronary atherosclerosis, to optimize the algorithm for diagnosis and to evaluate its effectiveness
- Trial name
- NOCA (NCT02655718)
- Testing
- Patients with ACS, MRI
- Where
- Russia
- Volunteers
- 200 people
- Sponsor
- Russian Academy of Medical Sciences
Acute Coronary Syndrome
Multi-Markers In the Diagnosis of Acute Coronary Syndrome
This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome).
- Trial name
- Midas 3 (NCT01134913)
- Where
- 6 sites in United States
- Volunteers
- 621 people
- Sponsor
- Abbott RDx Cardiometabolic
Acute Coronary Syndrome
Use of Ticagrelor in Korean ACS Patients: The BRILIANT KOREA Registry
Patients with acute coronary syndrome (ACS) require platelet inhibition after treatment. P2Y12 receptor blockage is a well-known, proved method of urgent and effective blockade of the platelet activation, and is applied to the…
- Trial name
- NCT02521038
- Testing
- Brilinta
- Where
- South Korea
- Volunteers
- 2,000 people
- Sponsor
- Seoul National University Hospital
Acute Coronary Syndrome
Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI
The goal of acute coronary syndrome (ACS) therapy is to successfully restore both epicardial blood flow and myocardial perfusion.
- Trial name
- NCT02201667
- Testing
- Ticagrelor, clopidogrel, Aspirin
- Where
- China
- Volunteers
- 444 people
- Sponsor
- RenJi Hospital
Substance Use Disorder, Opioid Use Disorder, Moderate
EXHIT ENTRE Comparative Effectiveness Trial
This study is a multi-site open-label randomized comparative effectiveness trial of a 28-day formulation of extended-release buprenorphine (XR-BUP) versus treatment as usual (TAU) for hospitalized patients with a moderate or…
- Conditions
- Substance Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe
- Trial name
- EXHITENTRE (NCT04345718)
- Testing
- Extended Release Buprenorphine, Treatment as Usual
- Where
- 6 sites in United States
- Volunteers
- 344 people
- Sponsor
- Gavin Bart
Unstable Anginas, Non ST Segment Elevation Myocardial Infarction
OCT Evaluation of Early Vascular Repair in Patients With Non ST Elevation Acute Coronary Syndrome (NSTE-ACS)
This is a prospective study of a new generation of drug-eluting stent in the treatment of non ST elevation acute coronary syndrome (NSTE-ACS).
- Trial name
- EXPECT (NCT04375319)
- Testing
- OCT
- Where
- 2 sites in China
- Volunteers
- 60 people
- Sponsor
- Xuzhou Third People's Hospital
Coronary Artery Disease
Assessment of Distal Protection Device in Patients at High Risk for Distal Embolism in Acute Coronary Syndrome (ACS)
Attenuated plaque ≥ 5mm by intravascular ultrasound(IVUS) was reported to be high risk for distal embolism in Acute coronary syndrome(ACS).
- Trial name
- VAMPIRE3 (NCT01460966)
- Testing
- Filtrap™ + Thrombus aspiration catheter, Thrombus aspiration catheter
- Where
- Japan
- Volunteers
- 200 people
- Sponsor
- Yokohama City University Medical Center
Coronary Artery Disease (CAD)
GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation
After a stent procedure, it is common practice to prescribe anti-platelet medication to prevent the blood from clotting. The main objective of this study is to determine if there is a better medication strategy to prevent blood…
- Trial name
- NCT01813435
- Testing
- Ticagrelor, Acetylsalicylic Acid, Clopidogrel
- Where
- 130 sites in Australia, Austria and 16 more
- Volunteers
- 15,991 people
- Sponsor
- ECRI bv
Acute Myocardial Infarction
Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS
The aim of this study is to demonstrate that a combined troponin and copeptin assay can exclude non-ST+ ACS in patients with chest pain less than 6 hours old.
- Trial name
- CopSCA (NCT05902117)
- Testing
- Troponin and Copeptin assay
- Where
- 2 sites in France
- Volunteers
- 270 people
- Sponsor
- Hôpital NOVO
Acute Coronary Syndrome, Angina, Unstable
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Patients with troponin-negative acute coronary syndrome (ACS) are not routinely pre-treated with P2Y12 inhibitors and the rate of high on-treatment platelet reactivity (HPR) remains elevated after a loading dose of ticagrelor at…
- Trial name
- NCT02925923
- Testing
- Ticagrelor, Eptifibatide, Clopidogrel
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Alabama at Birmingham
Acute Coronary Syndrome
The ACS Ethnicity Platelet Function Study
This study is being done to assess the effects of the CTP inhibitor on the function of your platelets (cells within your blood that are involved in the formation of blood clots) and to assess whether you have responded to the…
- Trial name
- NCT01829659
- Testing
- Ticagrelor
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Medstar Health Research Institute
Coronary, Coronary Artery Disease
CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
The CAPRA-EVO trial is a single-center, randomized, open-label study with blinded endpoint assessment comparing early evolocumab plus standard lipid-lowering therapy versus standard-of-care lipid-lowering therapy in patients with…
- Trial name
- CAPRA-EVO (NCT07612774)
- Testing
- Evolocumab, Serial photon-counting coronary computed tomography angiography, Standard Lipid-Lowering Therapy
- Where
- 2 sites in China
- Volunteers
- 232 people
- Sponsor
- West China Hospital
Acute Coronary Syndrome, Myocardial Infarction
Point of Care (POC) Biomarkers of Ischemia
Acute coronary syndrome is defined as myocardial infarction or ischemia as evidenced by significant coronary artery disease on cardiac catheterization/revascularization or reversible defect seen on stress test.
- Trial name
- NCT02039882
- Where
- United States
- Volunteers
- 85 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
OSA, ACS - Acute Coronary Syndrome
Impact of OSA on Outcomes in Acute Coronary Syndrome
Elucidating the effects of obstructive sleep apnea (OSA) on cardiovascular outcomes in acute coronary syndrome (ACS) is crucial in risk assessments and therapeutic recommendations for affected individuals.
- Conditions
- OSA, ACS - Acute Coronary Syndrome, Major Adverse Cardiac Events
- Trial name
- ISAACS (NCT03793582)
- Testing
- ApneaLink Type III portable sleep study
- Where
- United States
- Volunteers
- 128 people
- Sponsor
- MetroHealth Medical Center
Liver Surgery, Hepatectomy
ACS-NSQIP Calculator for Liver Surgery
The American College of Surgeons National Surgical Quality Improvement Program's (ACS-NSQIP) calculator has been endorsed by the surgeons' community to counsel patients and relatives regarding estimated postoperative…
- Conditions
- Liver Surgery, Hepatectomy, Outcome After Hepatectomy
- Trial name
- NCT03793933
- Testing
- Liver resection
- Volunteers
- 450 people
- Sponsor
- Humanitas Clinical and Research Center
Coronary Arterial Disease (CAD), Plaque
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With Stable Angina or ACS - A Traditional Feasibility Study
ICECAP is a multi-centre, prospective, single-arm, interventional, traditional feasibility clinical investigation to evaluate the efficacy and safety of intra-coronary cryotherapy on vulnerable or high-risk plaque (HRP), using…
- Conditions
- Coronary Arterial Disease (CAD), Plaque, Vulnerable Plaque, Cryotherapy
- Trial name
- ICECAP (NCT06939374)
- Testing
- Intracoronary Cryotherapy
- Where
- 3 sites in Belgium, United Kingdom
- Volunteers
- 30 people
- Sponsor
- Cryotherapeutics SA